Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
11.81 USD | -0.59% | -6.27% | -34.79% |
Kurzporträt
Mitarbeiterzahl: 158
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Novel Therapies
100,0
%
| 10 | 100,0 % | 2 | 100,0 % | -83.69% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 10 | 100,0 % | 2 | 100,0 % | -83.69% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Bernard Coulie
CEO | Chief Executive Officer | 58 | 01.02.16 |
- | - | ||
Keith Cummings
DFI | Director of Finance/CFO | 47 | 01.12.18 |
Chief Tech/Sci/R&D Officer | - | 04.01.21 | |
Eric Lefebvre
CTO | Chief Tech/Sci/R&D Officer | 60 | 01.05.18 |
Scott Turner
CTO | Chief Tech/Sci/R&D Officer | 53 | 01.07.21 |
Investor Relations Contact | - | 01.11.20 | |
Minnie Kuo
PRN | Corporate Officer/Principal | - | 14.09.23 |
Corporate Officer/Principal | - | - | |
Rik Derynck
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 12.01.21 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 01.07.16 |
Gayle Crowell
BRD | Director/Board Member | 73 | 08.01.20 |
Ho Young Huh
CHM | Chairman | 54 | 01.12.17 |
Bernard Coulie
CEO | Chief Executive Officer | 58 | 01.02.16 |
Thomas McCourt
BRD | Director/Board Member | 66 | 06.03.23 |
Darren Cline
BRD | Director/Board Member | 59 | 06.03.23 |
John Curnutte
BRD | Director/Board Member | 72 | 01.08.17 |
Smital Shah
BRD | Director/Board Member | 48 | 14.03.19 |
Katharine Knobil
BRD | Director/Board Member | 60 | 14.09.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 60 239 176 | 56 275 539 ( 93,42 %) | 0 | 93,42 % |
Unternehmenskontakt
Pliant Therapeutics, Inc.
260 Littlefield Avenue
94080, South San Francisco
+650 481 6770
http://www.pliantrx.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-34.79% | 717 Mio. | |
+25.83% | 653 Mrd. | |
+27.00% | 556 Mrd. | |
-6.76% | 354 Mrd. | |
+20.34% | 331 Mrd. | |
+3.00% | 296 Mrd. | |
+13.09% | 233 Mrd. | |
+5.46% | 201 Mrd. | |
-9.61% | 193 Mrd. | |
-6.26% | 144 Mrd. |
- Börse
- Aktien
- A2P4YV Aktie
- Unternehmen Pliant Therapeutics, Inc.